MINNEAPOLIS, March 3 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today the presentation of the findings of three studies on its Urgent(R) PC Neuromodulation System, a proprietary, minimally invasive nerve stimulation device, designed for office-based treatment of overactive bladder (OAB) symptoms, at the Society of Urologic Nurses and Associates (SUNA) Annual Symposium in Tampa, Florida. These retrospective and observational studies examined the use of the Urgent PC to deliver percutaneous tibial nerve stimulation (PTNS) for the treatment of OAB symptoms of urinary urgency, urinary frequency, and urge incontinence.
"These studies found that the Urgent PC is a viable, well-tolerated, nondrug option for the delivery of PTNS for treatment of OAB symptoms. The studies also reported reductions in the frequency of unwanted voids and incontinence, as well as a high level of self-reported patient satisfaction," said Dave Kaysen, the President and Chief Executive Officer of Uroplasty, Inc. "We believe, from a practice perspective, that Urgent PC is an effective, easy-to-administer treatment easily incorporated into routine patient care in an office setting."
In an oral presentation, "Percutaneous Tibial Nerve Stimulation:
Revival of an Old Technology for Treatment of Overactive Bladder," Leslie
Wooldridge, MSN, RNCS, GNP.F, BCIA-PMBD, Director of the Bladder Control
Clinic from Hackley Health at the Lakes Women's Center in Muskegon,
Michigan, presented results of 24 patients, who completed the initial
twelve, 30-minute weekly Urgent PC treatments. Of the 24 patients, 19
patients with successful results transitioned to maintenance therapy with
longer intervals between treatments. Two did not find the Urgent PC
effective enough to continue the treatments and three discontinued the
treatment for reasons unrelated to the treatment itself. Patients found a
reduction in the daily average number of day voids from 11.16 to 8, night
|SOURCE Uroplasty, Inc.|
Copyright©2008 PR Newswire.
All rights reserved